Long-term prognostic value of the combination of EORTC risk group calculator and molecular markers in non-muscle-invasive bladder cancer patients treated with intravesical Bacille Calmette-Guérin (Q35245608)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Long-term prognostic value of the combination of EORTC risk group calculator and molecular markers in non-muscle-invasive bladder cancer patients treated with intravesical Bacille Calmette-Guérin	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

Long-term prognostic value of the combination of EORTC risk group calculator and molecular markers in non-muscle-invasive bladder cancer patients treated with intravesical Bacille Calmette-Guérin (English)

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

Shahrokh Shariat

13

object named as

Shahrokh F Shariat

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

Bas W.G. van Rhijn

4

object named as

Bas Van Rhijn

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

Alexandre R. Zlotta

15

object named as

Alexandre R Zlotta

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

Michael A.S. Jewett

7

object named as

Michael Jewett

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

author name string

Sultan S Alkhateeb

1

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

Mischel Neill

2

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

Sas Bar-Moshe

3

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

David M Kakiashvili

5

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

Neil Fleshner

6

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

Michel Petein

8

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

Claude Schulman

9

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

Sally Hanna

10

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

Peter J Bostrom

11

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

Thierry Roumeguere

12

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

Sandrine Rorive

14

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

publication date

1 September 2011

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

119-126

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

Biomarkers in bladder cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3183702

12 July 2018

Prognostic markers in cancer: the evolution of evidence from single studies to meta-analysis, and beyond

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3183702

12 July 2018

Combining a molecular profile with a clinical and pathological profile: biostatistical considerations

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3183702

12 July 2018

P21 and p27: roles in carcinogenesis and drug resistance

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3183702

12 July 2018

Predictive value of cell cycle biomarkers in nonmuscle invasive bladder transitional cell carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3183702

12 July 2018

Metallothionein expression as prognostic factor for transitional cell carcinoma of bladder

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3183702

12 July 2018

P53 as a prognostic marker for bladder cancer: a meta-analysis and review.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3183702

12 July 2018

Cell-cycle checkpoints and cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3183702

12 July 2018

Combined effects of p53, p21, and pRb expression in the progression of bladder transitional cell carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3183702

12 July 2018

p53, p21, pRB, and p16 expression predict clinical outcome in cystectomy with bladder cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3183702

12 July 2018

Multivariate analysis of the prognostic factors of primary superficial bladder cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3183702

12 July 2018

Humoral response against heat shock proteins and other mycobacterial antigens after intravesical treatment with bacille Calmette-Guérin (BCG) in patients with superficial bladder cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3183702

12 July 2018

Induction of WAF1/CIP1 by a p53-independent pathway

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3183702

12 July 2018

Predictive value of combined immunohistochemical markers in patients with pT1 urothelial carcinoma at radical cystectomy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3183702

26 September 2018

Cooperative effect of cell-cycle regulators expression on bladder cancer development and biologic aggressiveness.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3183702

26 September 2018

Use of combined apoptosis biomarkers for prediction of bladder cancer recurrence and mortality after radical cystectomy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3183702

26 September 2018

Correlation of cyclin D1 and E1 expression with bladder cancer presence, invasion, progression, and metastasis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3183702

26 September 2018

Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3183702

26 September 2018

Prognostic factors in stage T1 grade 3 bladder cancer survival: the role of G1-S modulators (p53, p21Waf1, p27kip1, Cyclin D1, and Cyclin D3) and proliferation index (ki67-MIB1).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3183702

26 September 2018

Intravesical bacillus Calmette-Guerin versus mitomycin C for superficial bladder cancer: a formal meta-analysis of comparative studies on recurrence and toxicity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3183702

26 September 2018

Effect of p21WAF1/CIP1 expression on tumor progression in bladder cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3183702

26 September 2018

Urinary cytokines during intravesical bacillus Calmette-Guerin therapy for superficial bladder cancer: processing, stability and prognostic value

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3183702

26 September 2018

Evolution and clinical significance of the T cell proliferative and cytokine response directed against the fibronectin binding antigen 85 complex of bacillus Calmette-Guerin during intravesical treatment of superficial bladder cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3183702

26 September 2018

Reproducibility of p53 immunohistochemistry in bladder tumors. National Cancer Institute, Bladder Tumor Marker Network

1 reference

https://pubmed.ncbi.nlm.nih.gov/21976923

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Urinary Interleukin-8 and 18 predict the response of superficial bladder cancer to intravesical therapy with bacillus Calmette-Guerin

1 reference

https://pubmed.ncbi.nlm.nih.gov/21976923

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cyclin D1 expression in papillary superficial bladder cancer: its association with other cell cycle-associated proteins, cell proliferation and clinical outcome

1 reference

https://pubmed.ncbi.nlm.nih.gov/21976923

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intravesical bacillus Calmette-Guerin reduces the risk of progression in patients with superficial bladder cancer: a meta-analysis of the published results of randomized clinical trials

1 reference

https://pubmed.ncbi.nlm.nih.gov/21976923

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A retrospective analysis of 153 patients treated with or without intravesical bacillus Calmette-Guerin for primary stage T1 grade 3 bladder cancer: recurrence, progression and survival

1 reference

https://pubmed.ncbi.nlm.nih.gov/21976923

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Correlation and prognostic significance of p53, p21WAF1/CIP1 and Ki-67 expression in patients with superficial bladder tumors treated with bacillus Calmette-Guerin intravesical therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/21976923

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Bcl-2 and p53 expressions in invasive bladder cancers

1 reference

https://pubmed.ncbi.nlm.nih.gov/21976923

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

p53 mutations in bladder tumors inactivate the transactivation of the p21 and Bax genes, and have a predictive value for the clinical outcome after bacillus Calmette-Guerin therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/21976923

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cyclin D1 overexpression lacks prognostic significance in superficial urinary bladder cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/21976923

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Recurrence and progression of stage T1, grade 3 transitional cell carcinoma of the bladder following intravesical immunotherapy with bacillus Calmette-Guerin

1 reference

https://pubmed.ncbi.nlm.nih.gov/21976923

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Contemporary management of stage T1 transitional cell carcinoma of the bladder

1 reference

https://pubmed.ncbi.nlm.nih.gov/21976923

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

p53 and ki67 expression as prognostic factors for cancer-related survival in stage T1 transitional cell bladder carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/21976923

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.4103/0974-7796.84954

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35245608&oldid=2265483713"